CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-25 | Mills Kenneth T. President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −1,500 | 269,000 | ||
| 2021-06-24 | Mills Kenneth T. President and CEO | Option exercise | +4,500 | $3.76 | $17K | 285,484 |
| 2021-06-24 | Mills Kenneth T. President and CEO | Sale | −4,500 | $40.02 | $180K | 280,984 |
| 2021-06-24 | Mills Kenneth T. President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −4,500 | 270,500 | ||
| 2021-06-04 | Tasse Daniel Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-04 | STUMP DAVID C Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-04 | KARABELAS ARGERIS N Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-04 | Glucksmann Alexandra Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-04 | Fox Allan M. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-04 | BESHAR LUKE M Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-04 | Abdun-Nabi Daniel Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-02-25 | Mills Kenneth T. President and CEO | Option exercise | +1,500 | $0.85 | $1K | 282,484 |
| 2021-02-25 | Mills Kenneth T. President and CEO | Sale | −1,500 | $40.77 | $61K | 280,984 |
| 2021-02-25 | Mills Kenneth T. President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −1,500 | 39,670 | ||
| 2021-02-12 | Christmas Patrick J. Chief Legal Officer | Option exercise | +4,701 | $12.10 | $57K | 21,073 |
| 2021-02-12 | Christmas Patrick J. Chief Legal Officer | Sale | −4,701 | $49.08 | $231K | 16,372 |
| 2021-02-12 | Christmas Patrick J. Chief Legal Officer | Option exercise · Employee Stock Option (Right to Buy) | −4,701 | 6,430 | ||
| 2021-02-08 | Christmas Patrick J. Chief Legal Officer | Option exercise | +1,300 | $12.10 | $16K | 17,672 |
| 2021-02-08 | Christmas Patrick J. Chief Legal Officer | Sale | −1,300 | $49.11 | $64K | 16,372 |
| 2021-02-08 | Christmas Patrick J. Chief Legal Officer | Option exercise · Employee Stock Option (Right to Buy) | −1,300 | 11,131 |
Page 17 of 25 · 494 trades